AXIKIN PHARMACEUTICALS INC — Form D
AXIKIN PHARMACEUTICALS INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-29. The offering totals $11.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-03-29
- Form: D
- Accession: 0001439059-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $11.0M
- Amount sold: $2.0M
- Remaining: $9.0M
- Investors: 2
- Date of first sale: 2012-03-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-175874
Issuer
- Name: AXIKIN PHARMACEUTICALS INC
- CIK: 0001439059
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 10835 Road To The Cure, SAN DIEGO, CA, 92121
- Phone: 858-458-1890
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Walter CM Olesiak | Director | New York, NY |
| Fred A Middleton | Director | Chapel Hill, NC |
| Peter CM McWilliams | Director | San Francisco, CA |
| Peter CM McWilliams | Executive Officer | San Francisco, CA |
| Kevin B Bacon | Director | San Diego, CA |
| Kevin B Bacon | Executive Officer | San Diego, CA |
| Masaji CM Matsuoka | Director | Menlo Park, CA |
| Dan CM Liu | Director | Menlo Park, CA |
Other filings by this issuer (3)
More